STEREOTACTIC HYPO-FRACTIONAL RADIOTHERAPY OF PATIENTS WITH LUNG CANCER I-IIA CLINICAL STAGE: THE ROLE OF SUVMAX ASSESSMENT IN 18F-FDG PET/CT FOR MONITORING TREATMENT OUTCOMES. (2017). Voprosy Onkologii, 63(4), 632-638. https://doi.org/10.37469/0507-3758-2017-63-4-632-638